Medicinova vs Shattuck Labs
Shattuck Labs is the larger business, with $1.0m of revenue in fiscal 2025 against $409,657 for Medicinova (2.4 times as much). Medicinova grew faster (-59.0% against -82.5%). Medicinova kept more of each dollar of sales as profit: a net margin of -2928.8% against -4880.9%. Medicinova carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | MedicinovaMNOV, 2025 | Shattuck LabsSTTK, 2025 |
|---|---|---|
| Revenue | $409,657 | $1.0m |
| Revenue growth | -59.0% | -82.5% |
| Net income | −$12.0m | −$48.8m |
| Operating margin | -3242.5% | -5150.8% |
| Net margin | -2928.8% | -4880.9% |
| Return on equity | -23.1% | -60.3% |
| Free cash flow | −$9.8m | −$40.0m |
| Cash | $30.8m | $54.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 40 |
| Market value | $70.9m | $546m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 1 sales | 1 buys, 6 sales |